In intrahepatic cholangiocarcinoma, FTO inhibited angiogenesis and tumor cell migration via upregulating C-C motif chemokine ligand 19 (CCL19) expression [31]. The gene discussed is CCL19; the disease is intrahepatic cholangiocarcinoma.